Global Obesity Pipeline Report H1 2016 - Review of 98 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Obesity - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Obesity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with the latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Obesity and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter-strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Obesity Overview
  3. Therapeutics Development
  4. Pipeline Products for Obesity - Overview
  5. Pipeline Products for Obesity - Comparative Analysis
  6. Obesity - Therapeutics under Development by Companies
  7. Obesity - Therapeutics under Investigation by Universities/Institutes
  8. Obesity Products Glance
  9. Late-Stage Products
  10. Clinical-Stage Products
  11. Early-Stage Products
  12. Obesity - Products under Development by Companies
  13. Obesity - Products under Investigation by Universities/Institutes
  14. Obesity - Companies Involved in Therapeutics Development
  • Abeome Corporation
  • Advinus Therapeutics Ltd.
  • Aegis Therapeutics, LLC
  • Akron Molecules AG
  • Alize Pharma SAS
  • Amabiotics SAS
  • Ambrx, Inc.
  • Amgen Inc.
  • Arena Pharmaceuticals, Inc.
  • AstraZeneca Plc
  • Asubio Pharma Co., Ltd.
  • AtheroNova Inc.
  • Athersys, Inc.
  • Avaxia Biologics, Inc.
  • BioLingus AG
  • Biophytis SAS
  • BioRestorative Therapies, Inc.
  • BioTime, Inc.
  • Boehringer Ingelheim GmbH
  • Braasch Biotech LLC
  • Bristol-Myers Squibb Company
  • Camurus AB
  • Carmot Therapeutics, Inc.
  • Chronos Therapeutics Limited
  • CohBar, Inc.
  • CoMentis, Inc.
  • Corium International, Inc.
  • Daiichi Sankyo Company, Limited
  • Diabetica Limited
  • DiscoveryBiomed, Inc.
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Esperion Therapeutics, Inc.
  • Eternygen GmbH
  • Euroscreen S.A.

For more information visit http://www.researchandmarkets.com/research/fc2hws/obesity.

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Anti-Obesity Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Anti-Obesity Drugs